Novavax Files with the U.S. FDA for Updated Protein-based COVID-19 Vaccine

If authorized, Novavax is committed to deliver the only protein-based COVID-19 option in the U.S this fall.

Our Environmental, Social and Governance Approach

Novavax is on a mission to protect the health of people everywhere while supporting vaccine access, the environment, our workforce and adhering to the highest governance standards.

child holding plant
Life at Novavax

Explore our open positions, Global Total Rewards and what it means to be a SuperNova.

woman in lab

Information about our vaccine for Healthcare Professionals

Visit our authorization website for information on ordering, efficacy, safety and other information.

Needle icon

Novavax's Investor Hub

Visit our Investor Hub to access investor resources and information on upcoming and past events. Sign up to receive notifications for investor updates, such as upcoming events and webcasts, daily closing stock price, SEC filings and press releases.

circle graph icon

Latest press releases


What is a protein-based vaccine?


Antibodies and immunity: Does vaccine protection last?

Who we are

Novavax is powered by global collaborations